Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Status:
Completed
Trial end date:
2019-04-19
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to find out the dose of enzalutamide that can be safely
given with gemcitabine and cisplatin in patients with advanced bladder cancer. Researchers
also want to find out the side effects of these drugs when given together. This study will
also help in finding out the effect on tumor of the combination of enzalutamide, gemcitabine
and cisplatin.
Phase:
Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute